Pharmaceutical Executive Editorial Staff

U.S. Food and Drug Administration has greenlighted the use of Trodelvy for a third indication.

The Ad Club is leveraging AnyClip's AI-powered genius+ platform to drive discoverability, in-video search and interactivity to deliver their robust library of club programming to its members.

Sysnav Healthcare and Roche enter a partnership to facilitate development of industry standard outcome measurements in diseases associated with movement impairments, as well as designing the next generation of wearable technology based on Sysnav's technology.

"AH-ha!™ It's Acne Hormones" features people affected by acne and highlights "AH-ha" moments to "pop" common acne myths and misconceptions.

Launch Ready from Day One is designed to empower a company's customer facing teams to drive demand, simplify access, and create a seamless and more integrated customer experience.

Pete O'Heeron, founder, chairman, and CEO of FibroBiologics, explains the key principles that biotechnology companies should follow.

New structure strengthens offerings and drives the addition of diversified marketing services.

Adding more than 100 employees to its team in 2022, the company's growth has outpaced growth in the broader healthcare advertising segment, as pharmaceutical marketers increasingly embrace digital advertising, particularly on CTV.

Indegene expands on significant presence by adding to existing UK, Ireland, and Switzerland centers.

In its ninth year, the survey includes the opinions of over 240 US-based patient groups on the performance of the pharmaceutical industry in 2021.

The HBA announced the 2023 Woman of the Year, Honorable Mentor, and STAR recipients.

The report highlights various treatments for HIV, Parkinson's disease, Crohn's disease, alopecia, multiple myeloma, and breast cancer.

The Anglo-Swedish drugmaker on Monday agreed to pay $26 per CinCor share in cash, or $1.3 billion in total, a premium of nearly 121% to the U.S.-based company's closing price on Friday.

Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.

AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.

Personalized medicine continued its growth over the past year and became one of the most talked about topics in the life sciences industry.

Over the past year, the life sciences industry has experienced a variety of important innovations, while also facing an unstable economy. These factors were clearly on readers minds and helped shape the top stories of the year.

Marchesini will serve as Senior Vice President to help life sciences companies improve the effectiveness and efficiency of their commercial processes and go-to-market approach.

Katya Petrova will be responsible for providing JUICE clients with direction and oversight from inception through execution.

The FDA tapped the Reagan-Udall Foundation to launch the initiative.

Lang spoke with Pharm Exec about how recent market conditions impacted pharma this year and how things may change in the coming year.

Amgen spending big to dive deeper into rare disease treatments through deal for drugmaker Horizon Therapeutics.

Inc. 2022 Best in Business Award marks health-focused TogoRun's second year as an independent, woman-owned agency.

Built on Algorand, and in partnership with the Government of Maharashtra in India, NFT technology will be used for storing personal health data for the first time.

Brand Institute, naming agency, shares insights on emerging clinical trial naming trends.

The move bolsters Evoke’s digital innovation and omnichannel offering.

The International Federation of Pharmaceutical Manufacturers and Associations commissioned Ipsos to perform the research.

Over half of life sciences companies are not fully optimizing HCP engagement, according to the study.

Tech company Evermed provides modular content hubs that power personalized video content delivery for life science companies and HCPs.